Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...

People can get prescription weight loss drugs with an in-person visit to a ... Semaglutide medications include Wegovy and Ozempic. Additionally, 2022 research found that tirzepatide medications ...

Patients and doctors reflect on the reality of living with GLP-1 drugs ... prescription has been a significant financial ...

Millions of Medicare enrollees are likely to see relief in 2025 when a $2,000 cap on out-of-pocket prescription drug-spending ...

Next up, the prescription weight loss drug lorcaserin (Belviq) was recalled by the FDA over cancer concerns in 2020, after more than a decade on the market. After so many weight loss drugs were ...

The South, which had the highest prescription rates for these medications, showed notable improvements in obesity rates. ExploreOzempic, weight loss drugs send ripples through Atlanta health and ...

While recent advances in medicine have created prescription ... Act in 2022 allowed the Medicare program to negotiate drug prices down. This benefit now applies to some weight-loss drugs, which ...

While Ozempic and other GLP weight loss medications have surged in popularity, there are continuing concerns about some side effects, such as nausea, diarrhea, constipation, stomach pain and other ...

Wegovy, the weight loss medication you can only get with a prescription from a licensed ... This means that weight loss drugs like Wegovy are often excluded from health insurance coverage.